Log in to save to my catalogue

The host-directed therapeutic imatinib mesylate accelerates immune responses to Mycobacterium marinu...

The host-directed therapeutic imatinib mesylate accelerates immune responses to Mycobacterium marinu...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2826806079

The host-directed therapeutic imatinib mesylate accelerates immune responses to Mycobacterium marinum infection and limits pathology associated with granulomas

About this item

Full title

The host-directed therapeutic imatinib mesylate accelerates immune responses to Mycobacterium marinum infection and limits pathology associated with granulomas

Publisher

United States: Public Library of Science

Journal title

PLoS pathogens, 2023-05, Vol.19 (5), p.e1011387

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

Infections caused by members of the mycobacterium tuberculosis complex [MTC] and nontuberculous mycobacteria [NTM] can induce widespread morbidity and mortality in people. Mycobacterial infections cause both a delayed immune response, which limits rate of bacterial clearance, and formation of granulomas, which contain bacterial spread, but also con...

Alternative Titles

Full title

The host-directed therapeutic imatinib mesylate accelerates immune responses to Mycobacterium marinum infection and limits pathology associated with granulomas

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_2826806079

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2826806079

Other Identifiers

ISSN

1553-7374,1553-7366

E-ISSN

1553-7374

DOI

10.1371/journal.ppat.1011387

How to access this item